hematoporphyrin has been researched along with Nasopharyngeal Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, CB; Li, XH; Liu, ZG; Tao, YL; Tu, ZW; Xia, YF; Xu, BQ; Yi, W | 1 |
1 other study(ies) available for hematoporphyrin and Nasopharyngeal Carcinoma
| Article | Year |
|---|---|
Forty-six cases of nasopharyngeal carcinoma treated with 50 Gy radiotherapy plus hematoporphyrin derivative: 20 years of follow-up and outcomes from the Sun Yat-sen University Cancer Center.
Topics: Adult; Aged; Carcinoma; Female; Follow-Up Studies; Hematoporphyrins; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Quality of Life; Radiotherapy Dosage; Survival Analysis; Treatment Outcome | 2016 |